Richard Auchus, MD, PhD
Richard J. Auchus, MD, PhD
Brief Biography.
Dr. Auchus is the James A. Shayman and Andrea S. Kevrick Professor of Translational Medicine in the Departments of Pharmacology and Internal Medicine at the University of Michigan. He also serves as Chief of the Endocrinology Section at the Veterans Affairs Ann Arbor Healthcare System. Dr. Auchus and his group are active in research projects ranging from basic chemical principles of steroid biosynthetic enzymes and steroid mass spectrometry to clinical trials and translational investigation in disorders of the pituitary, adrenal, ovaries, and testes that cause hypertension, infertility, and obesity. His clinical interests also focus on pituitary, adrenal, and reproductive diseases that involve disorders of steroid production, and he is particularly interested in the care of adults with genetic disorders of steroid biosynthesis and action. He has authored more than 320 journal articles and 30 book chapters, and he has lectured in a wide range of national and international conferences. He was elected to the Association of American Physicians in 2018, and he is the 2021 recipient of the Outstanding Clinical Investigator Award from the Endocrine Society.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Novartis PharmaceuticalsDate added:06/06/2022Relationship end date:12/31/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Neurocrine BiosciencesDate added:06/06/2022Relationship end date:12/31/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Spruce BiosciencesDate added:06/06/2022Relationship end date:12/31/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Corcept TherapeuticsDate added:06/06/2022Relationship end date:12/31/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Diurnal, LTDDate added:06/06/2022Relationship end date:12/31/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Quest DiagnosticsDate added:06/06/2022Relationship end date:12/31/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Corcept TherapeuticsDate added:06/06/2022Relationship end date:12/31/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Janssen PharmaceuticalsDate added:06/06/2022Relationship end date:12/31/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Novartis PharmaceuticalsDate added:06/06/2022Relationship end date:12/31/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Strongbridge Biopharma/Xeris PharmaceuticalsDate added:06/06/2022Relationship end date:12/31/2025